Zacks Investment Research upgraded shares of Nmc Health Plc (NASDAQ:NMHLY) from a hold rating to a buy rating in a research report released on Thursday morning. The firm currently has $41.00 price objective on the stock.

According to Zacks, “NMC Health plc is an integrated private healthcare network operator primarily in the United Arab Emirates. The company also provides fertility treatments principally in European and Middle Eastern. NMC Health plc is based in London, the United Kingdom. “

Shares of Nmc Health Plc (NASDAQ NMHLY) remained flat at $36.63 on Thursday. Nmc Health Plc has a one year low of $17.32 and a one year high of $36.90. The stock has a market cap of $7.48 billion and a price-to-earnings ratio of 45.73.

COPYRIGHT VIOLATION WARNING: This news story was first published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this news story on another publication, it was illegally copied and reposted in violation of United States and international copyright and trademark law. The legal version of this news story can be viewed at https://www.thecerbatgem.com/2017/10/06/nmc-health-plc-nmhly-upgraded-by-zacks-investment-research-to-buy.html.

Receive News & Stock Ratings for Nmc Health Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nmc Health Plc and related stocks with our FREE daily email newsletter.